loading

Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie

pulisher
04:36 AM

Bellevue Group AG Boosts Stock Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat

04:36 AM
pulisher
Dec 10, 2025

Wall Street analysts’ outlook for Edgewise Therapeutics Inc (EWTX) - setenews.com

Dec 10, 2025
pulisher
Dec 09, 2025

Discipline and Rules-Based Execution in EWTX Response - news.stocktradersdaily.com

Dec 09, 2025
pulisher
Dec 07, 2025

Schroder Investment Management Group Has $1.98 Million Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat

Dec 07, 2025
pulisher
Dec 05, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Dec 05, 2025
pulisher
Dec 05, 2025

Analysts Offer Insights on Healthcare Companies: Nano-X Imaging (NNOX), Edgewise Therapeutics (EWTX) and BioNTech SE (BNTX) - The Globe and Mail

Dec 05, 2025
pulisher
Dec 04, 2025

EWTX SEC FilingsEdgewise Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 04, 2025
pulisher
Dec 03, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 5.4%Should You Sell? - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - Eastern Progress

Dec 03, 2025
pulisher
Dec 03, 2025

XTX Topco Ltd Takes Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Sio Capital Management LLC Acquires New Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Edgewise Therapeutics Advances with Phase 1 Study of EDG-15400 - MSN

Dec 03, 2025
pulisher
Dec 02, 2025

Edgewise Therapeutics reports inducement grants as permitted by the Nasdaq Listing Rules - marketscreener.com

Dec 02, 2025
pulisher
Dec 02, 2025

Edgewise Therapeutics (Nasdaq: EWTX) issues inducement option for 26,250 shares at $26.04 - Stock Titan

Dec 02, 2025
pulisher
Dec 02, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

Dec 02, 2025
pulisher
Dec 02, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 02, 2025
pulisher
Dec 01, 2025

Edgewise Therapeutics (EWTX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025
pulisher
Dec 01, 2025

Handelsbanken Fonder AB Increases Stake in Edgewise Therapeutics, Inc. $EWTX - Defense World

Dec 01, 2025
pulisher
Dec 01, 2025

Geode Capital Management LLC Raises Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat

Dec 01, 2025
pulisher
Nov 27, 2025

Universal Beteiligungs und Servicegesellschaft mbH Acquires 42,753 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat

Nov 27, 2025
pulisher
Nov 25, 2025

Is Edgewise Therapeutics Inc a good long term investmentHigh Dividend Yield Stocks & High Yield Portfolio Growth - earlytimes.in

Nov 25, 2025
pulisher
Nov 24, 2025

[Form 4] Edgewise Therapeutics, Inc. Insider Trading Activity - Stock Titan

Nov 24, 2025
pulisher
Nov 23, 2025

Edgewise Therapeutics Appoints Christopher Martin to Board - MSN

Nov 23, 2025
pulisher
Nov 22, 2025

Wall Street Zen Upgrades Edgewise Therapeutics (NASDAQ:EWTX) to "Hold" - MarketBeat

Nov 22, 2025
pulisher
Nov 21, 2025

Will Edgewise Therapeutics (EWTX) Gain a Commercial Edge With Its New Board Appointment? - Sahm

Nov 21, 2025
pulisher
Nov 21, 2025

Edgewise Therapeutics adds commercial biotech exec Martin to board - Investing.com

Nov 21, 2025
pulisher
Nov 20, 2025

Edgewise Therapeutics adds commercial biotech exec Martin to board By Investing.com - Investing.com Nigeria

Nov 20, 2025
pulisher
Nov 20, 2025

Edgewise Therapeutics Appoints Christopher Martin as Director - TradingView

Nov 20, 2025
pulisher
Nov 20, 2025

[8-K] Edgewise Therapeutics, Inc. Reports Material Event | EWTX SEC FilingForm 8-K - Stock Titan

Nov 20, 2025
pulisher
Nov 20, 2025

Edgewise Therapeutics appoints commercial biotech executive Christopher Martin to its Board of Directors - marketscreener.com

Nov 20, 2025
pulisher
Nov 20, 2025

Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin To Its Board Of Directors - TradingView

Nov 20, 2025
pulisher
Nov 20, 2025

Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors - WV News

Nov 20, 2025
pulisher
Nov 20, 2025

What is the fair value of Edgewise Therapeutics Inc. stock now2025 Market Outlook & Daily Stock Trend Watchlist - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

What recovery options are there for Edgewise Therapeutics Inc.Quarterly Performance Summary & Accurate Trade Setup Notifications - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Multi asset correlation models including Edgewise Therapeutics Inc.Weekly Trading Summary & Daily Profit Focused Stock Screening - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Exit strategy if you’re trapped in Edgewise Therapeutics Inc.Earnings Overview Report & Short-Term High Return Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to track smart money flows in Edgewise Therapeutics Inc.July 2025 Breakouts & Safe Entry Point Identification - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Will Edgewise Therapeutics’ (EWTX) New CFO Mark a Shift in Its Commercial Strategy? - Yahoo Finance

Nov 18, 2025
pulisher
Nov 18, 2025

Edgewise Therapeutics (EWTX): Assessing Valuation After Clinical Progress and New CFO Appointment - Sahm

Nov 18, 2025
pulisher
Nov 17, 2025

What valuation multiples suggest for Edgewise Therapeutics Inc. stockPrice Action & Free Technical Confirmation Trade Alerts - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

Shareholder Carruthers Files To Sell 70,000 Of Edgewise Therapeutics Inc [EWTX] - TradingView

Nov 17, 2025
pulisher
Nov 17, 2025

Order flow analysis tools used on Edgewise Therapeutics Inc.GDP Growth & Weekly Top Gainers Trade List - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

Edgewise Therapeutics chief business officer sells $300,300 in stock - MSN

Nov 17, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Capitalizzazione:     |  Volume (24 ore):